Droxinavir

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Droxinavir
Droxinavir structure.svg
Names
IUPAC name
3-tert-butyl-1-[(2R,3S)-3-[(2S)-3,3-dimethyl-2-[2-(methylamino)acetamido]butyramido]-2-hydroxy-4-phenylbutyl-1-isopentylurea
Other names
SC 55389A
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
Properties
C29H51N5O4
Molar mass 533.75 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N (what is ☑Y☒N ?)
Infobox references

Droxinavir (also known as SC 55389A) was an experimental protease inhibitor researched by Pharmacia as a treatment for HIV infection. Its research and development was discontinued on March 06, 1995.[1]

References[edit]

  1. ^ "Drug Profile: Droxinavir". AdisInsight. Adis International Ltd, part of Springer Science+Business Media. Retrieved 23 November 2015.